You are here

Prices & Quotes - UK Markets - FTSE AIM All-Share (AXX)

Risk Warning The value of investments can fall as well as rise and any income from them is not guaranteed and you may get back less than you invested. Past performance is not a guide to future performance.

Value:
Down 1,181.62
Change Today:
-22.34

Ixico FY revenues projected to beat expectations

By Iain Gilbert

Date: Monday 18 Oct 2021

LONDON (ShareCast) - (Sharecast News) - AI data analytics company Ixico said on Monday that full-year revenues were projected to have beat expectations despite falling shy of prior year comparatives.

Full-year revenues were anticipated to be £9.2m, down from £9.5m in 2020 but ahead of market expectations of £8.7m as year-on-year revenues remained broadly flat despite the impact of Covid-19 and lost revenues resulting from the company's largest client's move to cease dosing patients in its Huntington's Disease trials.

Ixico stated its year-end order book had slipped from £21.7m a year ago to £18.8m at the end of September, partly due to a £7.1m adverse impact from the aforementioned HD trials, while year-end cash slipped from £7.9m to £6.7m, reflecting a more than £2.0m technology investment to support long-term growth.

The AIM-listed group added that earnings before interest, tax, depreciation, and amortisation were expected to be "materially ahead of market expectations" of £1.2m and the previous year's print of £1.3m thanks to strong trading in the final quarter, "careful management" of discretionary costs and "several positive one-time impacts".

"Benefiting from a strong order book, and an improving business outlook resulting from the initiation of new neuroimaging clinical trials during the 2022 financial year, the company expects a return to revenue growth, albeit at a lower rate than recent historical levels," said Ixico.

However, Ixico added that over the coming year, it intends to continue to pursue its investment plan to accelerate long-term sustained growth, meaning it also expects to see lower profitability in 2022.

As of 1130 BST, Ixico shares were up 0.96% at 85.32p.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Price Data

Price 1,181.62
Change Today -22.34
26-Nov-21 Close 1,181.62

Top Risers

Price Change
Genedrive 23.20p +32.6%
Novacyt S.A. (CDI) 434.90p +31.0%
Inspirit Energy Holdings 0.048p +26.3%
Nanosynth group 0.72p +22.0%
MyHealthchecked 2.88p +12.9%
Eqtec (CDI) 1.42p +7.2%
Blue Prism Group 1,298.00p +6.8%
Synairgen 183.00p +6.4%
GoldStone Resources Ltd 12.88p +6.2%
Active Energy Group 0.38p +5.6%

Top Fallers

Price Change
Argos Resources Ltd. (DI) 0.68p -22.9%
ADM Energy 0.95p -22.4%
Bonhill Group 8.75p -20.5%
Quadrise Fuels International 2.39p -15.9%
Parkmead Group (The) 40.00p -14.9%
Westminster Group 3.33p -14.7%
Borders & Southern Petroleum 0.68p -14.5%
Velocys plc 8.02p -13.7%
Elixirr International 610.00p -13.5%
Jet2 977.20p -12.9%